Apple has found a new use for their iPhone - medicine. People had already created lots of apps, of course, but ResearchKit, due out next month, is the first Apple framework to make it easier. 

The framework allows new ways to create apps to track movement, take measurements, and record data and has three active modules: surveys, informed consent, and active tasks. Active tasks is the only one not intuitive - it means they can ask you to perform activities while the sensors are monitoring.

A new paper says they can detect sexism in a smile. 

A man’s true attitude towards the female sex can be detected according to how he smiles and chats to her, according to Jin Goh and Judith Hall of Northeastern University writing in Sex Roles. 

A new test that uses combinations of cells from a single donor’s blood can predict whether a new drug will cause a severe immune reaction in humans.

Drug discovery is an expensive, bureaucracy-laced process. Due to more restrictions requiring a lot more trials, drug discovery is an average 14 year process costing $2 billion and only 1 out of 5,000 drugs will get approved and out to the market. It's easy to imagine why once a company knows the product is not viable or safe, it is abandoned.

A Swiss teenager, recently returned home from a discotheque, came to the emergency department with classic sudden symptoms of stroke, only to be diagnosed with Lyme disease. The highly unusual case presentation was published in "Acute Lyme Neuroborreliosis with Transient Hemiparesis and Aphasia", Annals of Emergency Medicine.

Lighting technology is in a state of change. Incandescent bulbs, which have been around forever, have been banned in the United States but the heavily-subsidized replacement, compact fluorescent bulbs, run the risk of mercury poisoning if they break and have a glow that many don't find appealing. Light emitting diodes (LEDs) are likely the technology of choice in the mid-term future but they are expensive.